Glucose transporter protein 1-targeted RNA interference inhibits growth and invasion of the osteosarcoma cell line MG63 in vitro

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 5, 2010, Pages 521-527

  Fan, Jian ^a   Zhou, Jia Qian ^a   Yu, Guang Rong ^a   Lu, Dong Dong ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

gene therapy; Glut 1; osteosarcoma; small inference RNA

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; LENTIVIRUS VECTOR; MESSENGER RNA; SHORT HAIRPIN RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 77958176814     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2010.0784     Document Type: Article

References (18)

1. Warburg O. On the origin of cancer cells. Science 1956;123:309.
2. Wu X, Freeze HH. GLUT-14, a duplicon of GLUT-3, is specifically expressed in testis as alternative splice forms. Genomics 2002;80:553.
3. Ito H, Duxbury M, Zinner MJ, et al. Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity. Surgery 2004;136:548.
4. Vleugel MM, Greijer AE, Shvarts A, et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 2005;58:172.
5. Cooper R, Sarioglu S, Sokmen S, et al. Glucose transporter-1 (GLUT-1): A potential marker of prognosis in rectal carcinoma? Br J Cancer 2003;89:870.
6. Kunkel M, Reichert TE, Benz P, et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003;97:1015.
7. Endo M, Tateishi U, Seki K, et al. Prognostic implications of glucose transporter protein-1 (Glut-1) overexpression in bone and soft-tissue sarcomas. Jpn J Clin Oncol 2007;37:955.
8. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004;64:2627.
9. Cioca DP, Aoki Y, Kiyosawa K. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Ther 2003;10:125.
10. Pai S, Lin YY, Macaes B, et al. Prospects of RNA interference therapy for cancer. Gene Ther 2006;13:464.
11. Rudrappa SG, Humphrey BD. Energy metabolism in developing chicken lymphocytes is altered during the embryonic to posthatch transition. J Nutr 2007;137:427.
12. Wang S, Liu H, Ren L, et al. Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia 2008;10:399.
13. Longhi A, Errani C, De Paolis M, et al. Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat Rev 2006;32:423.
14. Hannon GJ. RNA interference. Nature 2002;418:244.
15. Cullen BR. Antiviral defense and genetic tool. Nat Immunol 2002;3:597.
16. Kato H, Takita J, Miyazaki T, et al. Correlation of 18-F- fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res 2003;23:3263.
17. Airley RE, Loncaster J, Raleigh JA, et al. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding. Int J Cancer 2003;104:85.
18. Li LY, Quarles LD, Zhou HH, et al. RNA interference and its application in bone-related diseases. Biochem Biophys Res Commun 2007;361:817.